Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer

The American Journal of Managed Care(2022)10.37765/ajmc.2022.88845Source: DataRank Database

Comparative effectiveness of larotrectinib and entrectinib for TRK fusion cancer is a research paper published in The American Journal of Managed Care (2022). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (31)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Josh J. Carlson ORCID

Live enrichment

PubMed:35201681 PMC:PMC11446158

NCATS NIH HHS

Grant: UL1 TR000124

NCATS NIH HHS

Grant: UL1 TR001881

National Institutes of Health

Grant: 3UL1TR001881-01S2

UCLA Clinical Translational Science Institute

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11446158

https://doi.org/10.37765/ajmc.2022.88845

https://pubmed.ncbi.nlm.nih.gov/35201681

https://escholarship.org/uc/item/77x852n9

https://escholarship.org/content/qt77x852n9/qt77x852n9.pdf

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansNeoplasmsBenzamidesPyrazolesIndazolesPyrimidinesProtein Kinase InhibitorsGene Fusion

Keywords

Comparative Effectiveness ResearchIndazolesClinical Trials and Supportive Activities610Rare DiseasesGood Health and Well BeingPyrimidinesClinical ResearchHealth Services and Systems6.1 PharmaceuticalsNeoplasmsHealth SciencesBenzamidesPublic Health and Health ServicesHealth Policy & ServicesHumansPyrazolesGene FusionProtein Kinase InhibitorsCancer

Sustainable Development Goals

SDG 3: 3. Good health